Litigation Details for BI-LO, LLC v. Bausch Health Companies Inc. (N.D. Cal. 2019)

✉ Email this page to a colleague

Docket	⤷ Sign Up	Date Filed	2019-09-27
Court	District Court, N.D. California	Date Terminated
Cause	15:15 Antitrust Litigation	Assigned To
Jury Demand	Plaintiff	Referred To
Patents	6,340,475; 6,488,962; 6,635,280; 6,723,340; 7,780,987; 8,323,692
Link to Docket	External link to docket

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2019-09-27	1	Complaint	1 Patent No. Expiration 6,340,475 (‘475 patent) …Book patent (the ‘692 patent), as well as two non-Orange Book listed patents 5 (the ‘667 patent and…listed patent(s) and/or the patent is 8 invalid and unenforceable. Simply by listing the patents in the…and U.S. Patent No. 8,329,215 (“the ‘215 patent”)). 6 192. The ‘215 patent, like the ‘667…plaintiffs in the 8 patent lawsuit, Assertio/Santarus, to the defendant in the patent lawsuit, Lupin. Lupin	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document